{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:26:00Z","timestamp":1787160360562,"version":"build-2736575974"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.intimp.2024.112234","type":"journal-article","created":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T17:08:18Z","timestamp":1715533698000},"page":"112234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["SDH, a novel diarylheptane compound, alleviates dextran sulfate sodium (DSS)-induced colitis by reducing Th1\/Th2\/Th17 induction and regulating the gut microbiota in mice"],"prefix":"10.1016","volume":"134","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2156-4193","authenticated-orcid":false,"given":"Fei","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9538-1445","authenticated-orcid":false,"given":"Ruyi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haimei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunsen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10401","key":"10.1016\/j.intimp.2024.112234_b0005","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(23)00966-2","article-title":"Ulcerative colitis","volume":"402","author":"Berre","year":"2023","journal-title":"Lancet"},{"issue":"10114","key":"10.1016\/j.intimp.2024.112234_b0010","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.intimp.2024.112234_b0015","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nrgastro.2015.150","article-title":"The global burden of IBD: from 2015 to 2025","volume":"12","author":"Kaplan","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.intimp.2024.112234_b0020","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nri3661","article-title":"Cytokines in inflammatory bowel disease","volume":"14","author":"Neurath","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2024.112234_b0025","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/ecco-jcc\/jjy215","article-title":"Neutrophil extracellular traps sustain inflammatory signals in ulcerative colitis","volume":"13","author":"Dinallo","year":"2019","journal-title":"J. Crohns Colitis"},{"issue":"12","key":"10.1016\/j.intimp.2024.112234_b0030","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1097\/MIB.0000000000000223","article-title":"Human gut dendritic cells drive aberrant gut-specific t-cell responses in ulcerative colitis, characterized by increased IL-4 production and loss of IL-22 and IFN\u03b3","volume":"20","author":"Mann","year":"2014","journal-title":"Inflamm. Bowel Dis."},{"issue":"3","key":"10.1016\/j.intimp.2024.112234_b0035","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41564-017-0089-z","article-title":"Dynamics of metatranscription in the inflammatory bowel disease gut microbiome","volume":"3","author":"Schirmer","year":"2018","journal-title":"Nat. Microbiol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112234_b0040","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3748\/wjg.v20.i1.6","article-title":"Immunopathology of inflammatory bowel disease","volume":"20","author":"Wallace","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.intimp.2024.112234_b0045","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.3389\/fimmu.2018.01212","article-title":"Effector T helper cell subsets in inflammatory bowel diseases","volume":"9","author":"Imam","year":"2018","journal-title":"Front. Immunol."},{"issue":"8766","key":"10.1016\/j.intimp.2024.112234_b0050","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/0140-6736(91)91133-F","article-title":"Treatment of inflammatory bowel disease with anti-CD4 monoclonal antibody","volume":"338","author":"Emmrich","year":"1991","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.intimp.2024.112234_b0055","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/gut.40.3.320","article-title":"CD4 antibody treatment in patients with active Crohn's disease: a phase 1 dose finding study","volume":"40","author":"Stronkhorst","year":"1997","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.intimp.2024.112234_b0060","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/1751-2980.12849","article-title":"Gut microbiota in ulcerative colitis: insights on pathogenesis and treatment","volume":"21","author":"Guo","year":"2020","journal-title":"J. Dig. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2024.112234_b0065","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3748\/wjg.v24.i1.5","article-title":"Relationship between intestinal microbiota and ulcerative colitis: Mechanisms and clinical application of probiotics and fecal microbiota transplantation","volume":"24","author":"Shen","year":"2018","journal-title":"World J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.intimp.2024.112234_b0070","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","article-title":"Interaction between microbiota and immunity in health and disease","volume":"30","author":"Zheng","year":"2020","journal-title":"Cell Res."},{"issue":"9","key":"10.1016\/j.intimp.2024.112234_b0075","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1186\/gb-2012-13-9-r79","article-title":"Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment","volume":"13","author":"Morgan","year":"2012","journal-title":"Genome Biol."},{"issue":"12","key":"10.1016\/j.intimp.2024.112234_b0080","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.3390\/biomedicines11123144","article-title":"The role of the microbiome in the pathogenesis and treatment of ulcerative colitis-a literature review","volume":"11","author":"\u015awirkosz","year":"2023","journal-title":"Biomedicines."},{"issue":"6","key":"10.1016\/j.intimp.2024.112234_b0085","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/s41385-020-00335-w","article-title":"Microbial modulation of intestinal T helper cell responses and implications for disease and therapy","volume":"13","author":"Geuking","year":"2020","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.intimp.2024.112234_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122612","article-title":"Gut microbiota as a key regulator of intestinal mucosal immunity","volume":"345","author":"Wang","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2024.112234_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113080","article-title":"SDH, a novel diarylheptane compound, is a potential treatment for inflammatory bowel disease by restoring epithelial barrier function","volume":"151","author":"Yang","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.intimp.2024.112234_b0100","doi-asserted-by":"crossref","first-page":"R60","DOI":"10.1186\/gb-2011-12-6-r60","article-title":"Metagenomic biomarker discovery and explanation","volume":"12","author":"Segata","year":"2011","journal-title":"Genome Biol."},{"issue":"3","key":"10.1016\/j.intimp.2024.112234_b0105","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.pop.2023.03.009","article-title":"Inflammatory Bowel Disease","volume":"50","author":"Bruner","year":"2023","journal-title":"Prim. Care"},{"issue":"1","key":"10.1016\/j.intimp.2024.112234_b0110","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00384-023-04417-6","article-title":"Trends in the prevalence and incidence of ulcerative colitis in Japan and the US","volume":"38","author":"Yamazaki","year":"2023","journal-title":"Int. J. Colorectal Dis."},{"issue":"8","key":"10.1016\/j.intimp.2024.112234_b0115","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.3390\/biomedicines11082249","article-title":"Inflammatory bowel disease: emerging therapies and future treatment strategies","volume":"11","author":"Bretto","year":"2023","journal-title":"Biomedicines."},{"issue":"1","key":"10.1016\/j.intimp.2024.112234_b0120","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41572-020-0205-x","article-title":"Ulcerative colitis","volume":"6","author":"Kobayashi","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"3","key":"10.1016\/j.intimp.2024.112234_b0125","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/1744666X.2023.2292768","article-title":"Management and treatment optimization of patients with mild to moderate ulcerative colitis","volume":"20","author":"D'Amico","year":"2024","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.intimp.2024.112234_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105075","article-title":"Inflammatory Bowel Disease - non-biological treatment","volume":"160","author":"Magro","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"6","key":"10.1016\/j.intimp.2024.112234_b0135","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00535-021-01784-1","article-title":"Evidence-based clinical practice guidelines for inflammatory bowel disease 2020","volume":"56","author":"Nakase","year":"2021","journal-title":"J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112234_b0140","doi-asserted-by":"crossref","first-page":"135","DOI":"10.7861\/clinmed.2021-0080","article-title":"Ulcerative colitis: an update","volume":"21","author":"Segal","year":"2021","journal-title":"Clin. Med. (Lond.)"},{"issue":"2","key":"10.1016\/j.intimp.2024.112234_b0145","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.vascn.2003.12.002","article-title":"Animal models of inflammatory bowel disease","volume":"50","author":"Jurjus","year":"2004","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.intimp.2024.112234_b0150","first-page":"7047201","article-title":"Th1\/Th2 balance and Th17\/Treg-mediated immunity in relation to murine resistance to dextran sulfate-induced colitis","author":"Yang","year":"2017","journal-title":"J. Immunol. Res."},{"issue":"27","key":"10.1016\/j.intimp.2024.112234_b0155","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1056\/NEJMra2002697","article-title":"Pathophysiology of inflammatory bowel diseases","volume":"383","author":"Chang","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.intimp.2024.112234_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.103017","article-title":"The influence of cytokines on the complex pathology of ulcerative colitis","volume":"21","author":"Nakase","year":"2022","journal-title":"Autoimmun. Rev."},{"issue":"2","key":"10.1016\/j.intimp.2024.112234_b0165","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41564-018-0306-4","article-title":"Gut microbiome structure and metabolic activity in inflammatory bowel disease","volume":"4","author":"Franzosa","year":"2019","journal-title":"Nat. Microbiol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924007537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924007537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T09:04:27Z","timestamp":1735290267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924007537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":33,"alternative-id":["S1567576924007537"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112234","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SDH, a novel diarylheptane compound, alleviates dextran sulfate sodium (DSS)-induced colitis by reducing Th1\/Th2\/Th17 induction and regulating the gut microbiota in mice","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112234","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112234"}}